News

New Breath Biopsy Panel May Help in COPD Diagnosis

A new, noninvasive breath biopsy panel — dubbed “a Breathalyzer for disease” — can distinguish several airway disorders, including chronic obstructive pulmonary disease (COPD), its developer said. Launched by Owlstone Medical, the panel may help in diagnosing COPD. The tool, officially called the Respiratory Diseases Research Use Only (RUO)…

Noninvasive Home Ventilation Linked to Lower Risk of Death, ER Visits

Noninvasive ventilation at home, known as NIVH, is associated with a significantly lower risk of death, hospitalization, and emergency room (ER) visits among chronic obstructive pulmonary disease (COPD) patients with chronic respiratory failure, according to a study based on Medicare data. Notably, the NIVH-associated reduced risk of hospitalization was…

Trixeo Aerosphere Approved in EU for COPD

The European Commission has approved AstraZeneca‘s triple combination therapy Trixeo Aerosphere as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The approval, which follows a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), covers the therapy’s use in adults with moderate-to-severe COPD…